Both drugs come as a liquid solution inside prefilled syringes, prefilled pens, and a single-dose vial for injection. Skyrizi also comes as a liquid solution in a cartridge for use with an on-body ...

One of these medicines, called Skyrizi, may help to improve symptoms in people who do not get enough benefit from other medicines that work on the body’s immune system. Swelling in the ...

One of these medicines, called Skyrizi, may help to improve symptoms in people who do not get enough benefit from oral medicines and certain types of injected medicines. The joints most often ...

AbbVie has received good news from the European Medicines Agency for a new use of its anti-inflammation drug Skyrizi, one of the best-selling products in its portfolio, now that blockbuster drug ...

AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for immunology powerhouses Skyrizi and Rinvoq by $4 billion. The company now projects more than ...

MONTREAL, March 4, 2025 /CNW/ - AbbVie (NYSE: ABBV) announced today that SKYRIZI® (risankizumab) is now available in Canada for the treatment of adults with moderately to severely active ...

AbbVie (ABBV) reported better-than-expected fourth-quarter results on Friday amid robust sales of Skyrizi and Rinvoq, ...